β-thalassemia major: Experience at King Fahad Hofuf Hospital, Al-Hassa, Saudi Arabia

Annals of Saudi Medicine

Volumn 16, Issue 5, 1996, Pages 560-563

  Laditan, Adewale Ayodele ^a   El Agib, Mohamed Amin ^a   Al Naeem, Saad ^a   Georgeos, Michael ^a   Khabour, Sameera ^a  

^a KING FAHAD HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SAUDI ARABIA; SCHOOL CHILD; SPLENECTOMY; TREATMENT OUTCOME;

EID: 0030003337     PISSN: 02564947     EISSN: None     Source Type: Journal    
DOI: 10.5144/0256-4947.1996.560     Document Type: Article

References (17)

1. Whipple GM, Bradford WL. Mediterranean disease - thalassemia (erythroblastic anemia of Cooley); associated pigment abnormalities simulating hemochromatosis. J Pediatr 1932;9:279-81.
2. Nienhuis AW, Benz EJ, Propper R, et al. Thalassemia major; molecular and clinical aspects. Ann Int Med 1979;91:883-97.
3. Kulosik AE. Beta thalassemia: molecular pathogenesis and clinical variability. Eu J Pediatr 1992;151:78-84.
4. Modell CB. Total management of β-thalassemia major. Arch Dis Childh 1977;52:489-97.
5. Economidou J. Problems related to the treatment of β-thalassemia major. Paediatrician 1982;11:157-77.
6. McIntosh N. Endocrinology in thalassemia major. Arch Dis Childh 1976;51:195-201.
7. Johnstone FE, Hertzog KP, Malina RM. Longitudinal growth in thalassemia major. AJ Dis Child 1966;112:396-401.
8. Engle MA. Cardiac involvement in Cooley's anemia. Ann NY Acad Sci 1964;119:694-702.
9. Propper RD, Cooper B, Ruffo RR, et al. Continuous administration of desferrioxamine in patients with iron overload. N Engl J Med 1977;297:418-23.
10. Osman M, Magbool G, Kaul KK. Hegira adaptation of the NCHS weight and height charts. Ann Saudi Med 1993;13:170-1.
11. Cao A, Gabutti V, Masera G, et al. Management protocol for the treatment of thalassemia patients. New York: Cooley's Anemia Foundation, 1992.
12. Munchi N, De-Silva V, White JM. The frequencies of Hb, S, α and β-thalassemia in Saudi Arabia: preliminary national values. Saudi Med J 1989;10:62-5.
13. Witzleben CL, Wyatt JP. The effect of long survival on the pathology of thalassemia major. J Pathol 1961;82:1-12.
14. O'Brien RT, Pearson HA, Spencer RP. Transfusion-induced decrease in spleen size in thalassemia major: documentation by radioisotopic scan. J Pediatr 1972;81:105-7.
15. Freedman MH. Management of β-thalassemia major using transfusion and iron chelation with desferrioxamine. Transfus Med Rev 1988;2:161-75.
16. Letsky E, Miller F, Worwood M, Flynn DM. Serum ferritin in children with thalassemia regularly transfused. J Clin Path 1974;27:652-5.
17. De Alarcon PA, Donovan ME. Iron absorption in thalassemic syndromes and its inhibition by tea. N Engl J Med 1979;300:5-8.